Cargando…
Safety of Pegfilgrastim (Neulasta) in Patients with Sickle Cell Trait/Anemia
Pegfilgrastim (Neulasta) is a recombinant filgrastim (human granulocyte colony-stimulating factor (G-CSF)) attached to a polyethylene glycol (PEG) molecule and is given as part of chemotherapy regimens that are associated with significant myelosuppression and risk for febrile neutropenia. Prescribin...
Autores principales: | Kasi, Pashtoon Murtaza, Patnaik, Mrinal M., Peethambaram, Prema P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874362/ https://www.ncbi.nlm.nih.gov/pubmed/24396616 http://dx.doi.org/10.1155/2013/146938 |
Ejemplares similares
-
Initial testing of pegfilgrastim (Neulasta Onpro) on‐body injector in multiple radiological imaging environments
por: Long, Zaiyang, et al.
Publicado: (2021) -
Immunogenicity and safety of a proposed pegfilgrastim biosimilar MSB11455 versus the reference pegfilgrastim Neulasta(®) in healthy subjects: A randomized, double‐blind trial
por: Wynne, Chris, et al.
Publicado: (2020) -
A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®)
por: Wong, Gina, et al.
Publicado: (2020) -
PF-06881894, a Proposed Biosimilar to Pegfilgrastim, Versus US-Licensed and EU-Approved Pegfilgrastim Reference Products (Neulasta(®)): Pharmacodynamics, Pharmacokinetics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers
por: Moosavi, Shahrzad, et al.
Publicado: (2020) -
The Use of Intravenous Neostigmine in Palliation of Severe Ileus
por: Kasi, Pashtoon Murtaza
Publicado: (2013)